Success Metrics

Clinical Success Rate
42.9%

Based on 3 completed trials

Completion Rate
43%(3/7)
Active Trials
24(49%)
Results Posted
0%(0 trials)
Terminated
4(8%)

Phase Distribution

Ph early_phase_1
1
2%
Ph not_applicable
15
31%
Ph phase_2
1
2%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution17 total trials
Early Phase 1First-in-human
1(5.9%)
Phase 2Efficacy & side effects
1(5.9%)
N/ANon-phased studies
15(88.2%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

42.9%

3 of 7 finished

Non-Completion Rate

57.1%

4 ended early

Currently Active

24

trials recruiting

Total Trials

49

all time

Status Distribution
Active(28)
Completed(3)
Terminated(4)
Other(14)

Detailed Status

Recruiting15
unknown14
Active, not recruiting9
Terminated4
Completed3
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
49
Active
24
Success Rate
42.9%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (5.9%)
Phase 21 (5.9%)
N/A15 (88.2%)

Trials by Status

completed36%
not_yet_recruiting24%
enrolling_by_invitation24%
active_not_recruiting918%
recruiting1531%
terminated48%
unknown1429%

Recent Activity

Clinical Trials (49)

Showing 20 of 49 trialsScroll for more
NCT07746024

Advancing Risk Stratification in Endometrial Cancer

Active Not Recruiting
NCT07735858

Microfluidic Urinary Exosome-Based Diagnostic Model for Bladder Cancer

Active Not Recruiting
NCT04258137Not Applicable

Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study

Active Not Recruiting
NCT03280394

Liquid Biopsy in Mature B-cell Tumors

Recruiting
NCT05049538

Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers

Recruiting
NCT06268405Not Applicable

Positron Emission Mammography and Liquid Biopsy in Women With High-risk Breast Screenings

Recruiting
NCT06067503Phase 2

Biomarkers to Detect Endocrine Therapy Resistance

Recruiting
NCT03265496Not Applicable

Correlation Between Tissue and Plasmatic EGFR in CBNPC With EGFR Mutation or Predictive Factor of EGFR Mutation

Terminated
NCT07418125Not Applicable

Studying the Role of Circulating Tumor Cell Clusters in Patients With High-risk Early Breast Cancer, Study GALIA

Recruiting
NCT05708599Not Applicable

A Study to Compare Tissue and Liquid Biopsies in People With Different Types of Cancer

Active Not Recruiting
NCT05868486Early Phase 1

Analysis of Whole Body Magnetic Resonance Imaging and Liquid Biopsy for Early Detection of Cancer in Patients With a Strong Family History of Cancer

Active Not Recruiting
NCT04863924

Accelerating Lung Cancer Diagnosis Through Liquid Biopsy

Active Not Recruiting
NCT04874064

TRIple Negative Breast Cancer Markers In Liquid Biopsies Using Artificial Intelligence

Recruiting
NCT06592716

Can Recurrence of Cancer in the Oropharynx be Detected by Blood Samples?

Active Not Recruiting
NCT05384769Not Applicable

Feasibility of Cell-Free DNA Liquid Biopsy in Screening High-Risk Patients for Lung Cancer

Recruiting
NCT04273542Not Applicable

Interest of Broadband Spectroscopy Analysis by Infrared Laser on Liquid Biopsies in Breast Cancer Screening

Active Not Recruiting
NCT04162678

Fluid Biopsy for the Diagnosis of Lung Cancer

Terminated
NCT05885009

Feasibility and Impact of Liquid Biopsy Genomic Profiling on Treatment Patients With Metastatic Prostate Cancer in Spain (SOLTI-2102)

Recruiting
NCT05810402Not Applicable

Liver Cancer and Immunotherapy in the Liquid Biopsy Era

Recruiting
NCT06991452

Early Diagnosis and Recurrence Monitoring of Colorectal Cancer

Not Yet Recruiting

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
49